Spravato has been approved since 2019 for TRD, with its label extended the following year as a rescue therapy for adults with major depressive disorder (MDD) who were at risk of self-harm or suicide.
Not sure what you are looking for?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback